| Last Trade | 120.10 |
| Change | (2.40) |
| Change (%) | (1.96) |
| Open | 122.50 |
| Low | 119.60 |
| High | 122.50 |
| Prev. Close | 122.50 |
| Change (3M) | (3.15 %) |
| Change (6M) | (21.25 %) |
| Volume | 89,530 |
| Turnover | 10,792,036.00 |
| Transactions | 1,329 |
| Market Value | 12,199.16 |
| Avg. Volume (3M) | 156,605.31 |
| Avg. Turnover (3M) | 17,814,559.12 |
| Avg. Transaction (3M) | 2,108.86 |
| Change (12M) | (4.38 %) |
| YTD | (4.30 %) |
|
Event Date
|
Event
|
||
|---|---|---|---|
|
07-04-2026
|
Cash Dividend Distribution | ||
|
24-03-2026
|
Ex-dividend Date | ||
|
30-11-2025
|
Cash Dividend Distribution | ||
|
10-11-2025
|
Ex-dividend Date | ||
|
19-10-2025
|
General Assembly | ||
| More | |||
| Report | Interim | Year |
| Dallah Health earns SAR 538.3M in 2025, SAR 116.6 M in Q4 | 12 M | 2025 |
| Dallah Health earns SAR 421.7M in 9M 2025, SAR 141.9M in Q3 | 9 M | 2025 |
| Dallah Health H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M | 6 M | 2025 |
| Dallah Health profit jumps 30% to SAR 155.6M in Q1 2025 | 3 M | 2025 |
| Date | Research firm | Rating |
|
|
AlJazira Capital | Overweight |
|
|
U-Capital | Buy |
|
|
AlphaMena | Underweight |
|
|
U-Capital | Hold |
